OBJECTIVE To review the results of endovascular treatment of acute thoracic aortic diseases in a group of Chinese patients. DESIGN Retrospective study. SETTING A tertiary referral hospital with a cardiothoracic surgery service. PATIENTS All 15 patients presenting with acute thoracic aortic diseases between September 2001 and October 2005 inclusive, of whom eight had traumatic rupture, fou...

Aortobronchial fistula (ABF) is a rare and potentially lethal complication of thoracic aortic replacement surgery. Currently, thoracic endovascular aortic repair (TEVAR) has emerged as a less invasive alternative to open surgery for ABF to facilitate prompt hemostasis. However, there are no published reports of TEVAR for ABF, particularly for presentation with life-threatening respiratory failu...

INTRODUCTION AND OBJECTIVES The aim of this work is to describe the short- and mid-term results of endovascular treatment of penetrating ulcers in the thoracic aorta. METHODS Between 1998 and 2010, 22 patients with penetrating ulcers in the thoracic aorta received endografts (mean age 69.8 years, 91% male); 50% were indicated for acute aortic syndrome (8 chest pain, 1 aortic rupture, 1 aortob...

INTRODUCTION We report mid-term results from the endovascular treatment of acute thoracic aortic pathologies in a single center. METHODS We retrospectively interrogated our clinical database and identified the following patients who were treated for an acute thoracic aortic pathology during a 3-year period (January 2003 to February 2006) with the deployment of a thoracic endograft: 8 male pat...

Aortobronchial fistula (ABF) is a rare, late, and usually catastrophic complication that should be suspected in any patient who has undergone a surgical procedure involving descending thoracic aorta. It usually presents as atypical chest pain that is followed by massive hemoptysis and death due to blood loss if emergency surgery is not performed. Our patientwas a 39-year-oldman,whose only notab...